Entera Bio Stock Fundamentals
Entera Bio fundamentals help investors to digest information that contributes to Entera Bio's financial success or failures. It also enables traders to predict the movement of Entera Stock. The fundamental analysis module provides a way to measure Entera Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Entera Bio stock.
Entera |
Entera Bio Company Net Income Analysis
Entera Bio's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Entera Bio Net Income | (13.07 M) |
Most of Entera Bio's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Entera Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Entera Bio reported net income of (13.07 Million). This is much lower than that of the Oil, Gas & Consumable Fuels sector and significantly lower than that of the Energy industry. The net income for all United States stocks is notably higher than that of the company.
Entera Bio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Entera Bio's current stock value. Our valuation model uses many indicators to compare Entera Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Entera Bio competition to find correlations between indicators driving Entera Bio's intrinsic value. More Info.Entera Bio is one of the top stocks in number of shares shorted category among its peers. It also is rated as one of the top companies in revenue category among its peers totaling about 91.91 of Revenue per Number Of Shares Shorted. Comparative valuation analysis is a catch-all technique that is used if you cannot value Entera Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Entera Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Entera Bio's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Entera Bio could also be used in its relative valuation, which is a method of valuing Entera Bio by comparing valuation metrics of similar companies.Entera Bio is currently under evaluation in net income category among its peers.
Entera Fundamentals
Number Of Shares Shorted | 1.46 K | |||
Revenue | 134 K | |||
EBITDA | (13.02 M) | |||
Net Income | (13.07 M) | |||
Total Debt | 91 K | |||
Cash Flow From Operations | (12.5 M) | |||
Total Asset | 13.13 M | |||
Retained Earnings | (95.5 M) | |||
Working Capital | 11.51 M | |||
Z Score | -12.39 | |||
Net Asset | 13.13 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Entera Stock
If you are still planning to invest in Entera Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Entera Bio's history and understand the potential risks before investing.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |